NorthCrest Asset Manangement’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
HWAM
LTAS
SAM
BC
YCM
COPPSERS
EF
MFG
NorthCrest Asset Manangement's CORT Position: Q2 2026 in Review
NorthCrest Asset Manangement opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 3,855 shares worth $359K. The stake represents 0.01% of the portfolio and ranks #669 among its holdings.
43 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- NorthCrest Asset Manangement held 3,855 shares of Corcept Therapeutics worth $359K as of Q2 2026.
- Corcept Therapeutics was a new NorthCrest Asset Manangement position in Q2 2026.
- Corcept Therapeutics made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #669 holding.
- 43 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.